What is it about?
EQA has a key role in post-market surveillance of methods and hence, in the detection of poorly performing assays. To maximize the impact and effectiveness of this role EQA providers will need to work together to harmonize the way they collect and present data.
Featured Image
Read the Original
This page is a summary of: Harmonising EQA schemes the next frontier: challenging the status quo, Clinical Chemistry and Laboratory Medicine (CCLM), May 2020, De Gruyter,
DOI: 10.1515/cclm-2020-0343.
You can read the full text:
Contributors
Be the first to contribute to this page







